category,datetime,headline,id,image,related,source,summary,url
company,1768258804,Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note,138083461,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,"Boston Scientific (BSX) reached $95.72 at the closing of the latest trading day, reflecting a -1.97% change compared to its last close.",https://finnhub.io/api/news?id=59e5a8ecc5c78d5ec3babc0fc242f83637c6758210508d0e604ad0df04672880
company,1768229760,GeneDx Partners With Komodo Health to Advance Rare Disease Research,138076573,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,"WGS collaborates with Komodo Health to link genomic data with real-world insights, expanding data monetization and strengthening its role in rare disease research.",https://finnhub.io/api/news?id=040c4e88092c977331511d1548d06934a4aaa8f30cded4880ea79cbf6279dcb4
company,1768227798,Boston Scientific to buy incontinence device maker Valencia,138083462,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that work by stimulating the tibial nerve.,https://finnhub.io/api/news?id=c5f276642313cb99e93e3d2f3bd970d78b1ac123e376361539c05e4b89225234
company,1768223340,Illumina's New Connected Multiomics Platform Set to Boost Its Stock,138072401,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,"ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.",https://finnhub.io/api/news?id=aa20238bffaa438523e4915688649873b19b2d640d93a783e7425a7e349a66e0
company,1768222800,"Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones",138071503,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,"Fourth quarter revenue up 16% year-over-year, $26.9M of secured debt eliminated, and total cash and escrowed proceeds of $44.3M at year-end GAITHERSBURG, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today provided a corporate update and outlined upcoming development milestones for NXT-41x, its next-generation antibiotic-eluting biomatrix program in plastic and reconstructive surgery. NXT-41x is El",https://finnhub.io/api/news?id=34ac79e55bfd0a75a316dcd5c91abb7d037896b41468ae94ad9b93d96eb32bf3
company,1768219200,Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation,138071504,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,"Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Valencia Technologies Corporation, a privately held medical technology company focused on the development and commercialization of innovative solutions to treat bladder dysfunction. The company's eCoin® System is an implantable tibial nerve stimulation (ITNS) device for the treatment of urge urinary incontinence (UUI), a common symptom of overactive bladder (OAB).",https://finnhub.io/api/news?id=0f415d40b19ab33785f66e17b5c374a70e3b07e89c2d1dd4c09cc8fd13cbf4a3
